Research shows how tumor cells evade T-cell immunotherapy

Adapted from press release by Max Delbrück Center for Molecular Medicine in the Helmholtz Association and the Berlin Institute of Health. Immunotherapy is a new and highly promising form of treatment for cancer. In many patients, however, tumors recur after immunotherapy. In the latest issue of the Journal of Experimental Medicine, the members of a …

Research shows how tumor cells evade T-cell immunotherapy Read More »